Co. Plans to Make 100M Rapid COVID Tests Monthly
  (1/5/22)
Biopharmaceutical firm Sorrento Therapeutics Inc. plans to mobilize a fully automated assembly line in San Diego, Calif., capable of producing 6 million rapid antigen detection COVISTIX testing units per month starting in Q1/22. More >

Tech Growth Pushes Co.'s Rating Higher
  (1/4/22)
"We expect strong datacom sales will enable II-VI to exceed Street expectations [in 2022]," noted a Raymond James report. More >

Oilfield Services Co. Projects 25% Revenue Growth for Q4
Source: Streetwise Reports  (1/4/22)
Shares of land-focused oil services firm NexTier Oilfield Solutions Inc. traded 27% higher after the company reported it expects Q4/21 revenues will be in the range of $500-510 million and advised that its 32-unit fracking rig fleet will be fully deployed in Q1/22. More >

Skyharbour Looks to New Uranium Claims
Source: Streetwise Reports  (1/3/22)
Skyharbour Resources Ltd. has staked six new prospective uranium exploration properties within and near the Athabasca Basin of northern Saskatchewan, which contains the world’s highest-grade uranium deposits. More >

Imperial Helium Expects Its First Sales in 2022
Source: Streetwise Reports  (1/3/22)
Imperial Helium’s second, future-producing helium well was spud on Dec. 6, 2021, amidst constrained global helium supply. The outlook is good for 2022. More >

Lead Cancer Drug Gets Fast Tracked
Source: Streetwise Reports  (1/3/22)
Shares of Genprex Inc. traded 165% higher after the company reported the U.S. FDA has awarded Fast Track Designation for its REQORSAâ„¢ Immunogene Therapy for use in combination with Merck & Co.'s Keytruda® for non-small cell lung cancer treatment. More >

Analyst: Drug a 'Hidden Gem for 2022'
  (12/31/21)
Oppenheimer ranks Astria Therapeutics Outperform after learning about its drug for hereditary angioedema, saying "We stay bullish." More >

Why This Gold Newcomer Is a 'Strong Buy'
Source: Streetwise Reports  (12/30/21)
Sitka Gold Corp's recently released new drill results at its RC Gold Project in the Yukon have grabbed investors' attention. More >

Co.'s COVID-19 Test Detects Omicron Variant
  (12/30/21)
H.C. Wainwright & Co. gives Sorrento Therapeutics a Buy rating after initial testing shows its COVISTIX detects COVID-19's Omicron variant. More >

Tech Firm Surging In Mobile Gaming Market
  (12/30/21)
"Pixelworks represents a differentiated investment opportunity in video display processing capabilities," noted a ROTH Capital Partners report. More >

Why Red Metal Resources Is a Standout
Source: BioResearchAlert  (12/30/21)
With copper continuing to soar and Chile electing a new president opposed to open pit mines, Red Metal Resources is a compelling standout. More >

Co. Looks To US For Help Fighting Strokes
Source: Streetwise Reports  (12/29/21)
Canadian company Algernon Pharmaceuticals Inc. has applied to uplist to the Nasdaq in hopes of attracting U.S. investors to its mission to repurpose drugs. More >

Co. Still Compelling After Drug Trial Failure
  (12/29/21)
"Arcalyst remains the value driver" for Kiniksa Pharmaceuticals, and "we continue to hold a favorable view of the company," noted a Wedbush report. More >

New CEO for Gold Terra: Gerald Panneton
Source: The Critical Investor  (12/28/21)
Although Gerald Panneton was already guiding Gold Terra as an Executive Chairman, it seems likely after this restructuring he will have full control being a Chairman and CEO effective January 1st, 2022. As he was used to be thinking big at Detour, the Critical Investor expects more of the same here. More >

Counting Down the Top Drill Holes of 2021
Source: Streetwise Reports  (12/28/21)
On any given business day, results from a drill hole can turn a Wednesday into Christmas Day for shareholders. We take a look at what experts think are the best drill holes of 2021. More >

Analyst Takes Year-End Stock of His Portfolio
Source: Adrian Day  (12/28/21)
In a year-end bulletin, Adrian Day gives a brief reminder of the fundamental reason for each stock in his portfolio, as well as to note the largest downside or risk for each. More >

Canadian Co. to Explore New Finnish Properties
Source: The Critical Investor  (12/28/21)
After a year of slow progress for Avrupa Minerals, management decided to create more opportunities by acquiring four exploration properties in Finland. More >

Why Invest in This Uranium Explorer Now
Source: Streetwise Reports  (12/27/21)
In the Dec. 22 episode of Streetwise Live!, influential uranium investor Terry Papineau tells why he believes now is the right time to invest in the uranium sector and, specifically, in Baselode Energy. Its CEO James Sykes discusses the company's new high-grade discovery and its work plan for 2022.

More >

Gold Mining to Commence at BC Project in Q1/22
  (12/27/21)
"The recovery of first gold from stage one of Omineca Mining and Metals' Wingdam placer project could be a major catalyst for the stock," noted a Research Capital report. More >

Silver Dollar Has Silver Eq at $.08 an Ounce
Source: Bob Moriarty  (12/26/21)
Bob Moriarty of 321Gold says that for astute investors, Silver Dollar Resources Inc. is a good bet into February regardless of what the rest of the market does. More >

Co. Rated Outperform As Heart Failure Drug Nears Potential Approval
  (12/25/21)
"Cytokinetics' pipeline of muscle-directed therapies has potential to address several diseases with high unmet medical need and may generate significant revenue across pipeline programs," noted an Oppenheimer report. More >

Analyst: Question Lingers Over Biotech’s Cell Therapy
  (12/23/21)
A DawsonJames report notes that Brainstorm Cell Therapeutics’ autologous stem cells in amyotrophic lateral sclerosis will need further study to prove their effectiveness.
More >

Coverage Initiated on Biopharma Co. After Turnaround Story
  (12/23/21)
"With Acasti Pharma shares trading near cash levels yet current resources sufficient to achieve key development milestones across the pipeline over 2022-2023, we recommend investors build a position," noted an Oppenheimer report.
More >

Coverage Initiated on Texas-Based Shrimp Farming Company
Source: Streetwise Reports  (12/23/21)
What differentiates NaturalShrimp is its proprietary technology that allows it to "produce recirculating aquaculture system-raised shrimp at a sufficient density for mass production," noted a ROTH Capital Partners report. More >

It's 'All Systems Go' for This Gold Co.
Source: Chris Temple  (12/23/21)
Chris Temple, editor and publisher of The National Investor, explains Omineca Mining & Metals' almost 50% increase and why his rationale for his initial recommendation of Omineca remains unchanged. More >